Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Champions Oncology (CSBR – Research Report), Walgreens Boots Alliance (WBA – Research Report) and Harrow Health (HROW – Research Report).
Champions Oncology (CSBR)
Craig-Hallum analyst Chase Knickerbocker assigned a Buy rating to Champions Oncology today. The company’s shares closed last Friday at $6.15.
According to TipRanks.com, Knickerbocker is a 4-star analyst with an average return of
Champions Oncology has an analyst consensus of Moderate Buy, with a price target consensus of $7.50.
See Insiders’ Hot Stocks on TipRanks >>
Walgreens Boots Alliance (WBA)
Jefferies analyst Brian Tanquilut reiterated a Hold rating on Walgreens Boots Alliance on October 13 and set a price target of $25.00. The company’s shares closed last Friday at $23.25, close to its 52-week low of $20.58.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Walgreens Boots Alliance with a $26.56 average price target, implying a 10.1% upside from current levels. In a report issued on October 5, J.P. Morgan also maintained a Hold rating on the stock with a $27.00 price target.
Harrow Health (HROW)
In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Harrow Health, with a price target of $45.00. The company’s shares closed last Friday at $14.98.
According to TipRanks.com, Mamtani ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Harrow Health has an analyst consensus of Strong Buy, with a price target consensus of $38.80.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CSBR:
